HONSUN

Background

HONSUN Medical, established in 2005, is headquartered in Nantong, Jiangsu. The company became listed enterprises on the Beijing Stock Exchange on November 15, 2021, with stock code 832278.

Its core business includes the R&D, production, and sales of home medical devices and health care products.

Key products include mechanical sphygmomanometers, electronic blood pressure monitors, nebulizers, stethoscopes, and oral irrigators. These products are exported to more than 100 countries and regions across Europe, Asia, America, Africa, and Oceania. Among them, mechanical sphygmomanometers and stethoscopes have ranked first globally in market share for multiple consecutive years.

In 2024, the company reported revenue of approximately RMB 350 million, a year-on-year increase of about 4.7%. As of December 2024, it held 113 authorized patents, including 9 invention patents.

Case details

• Products: cardiovascular monitoring, respiratory therapy, and home health equipment